Obsessive Compulsive Disorder is characterized by unreasonable thoughts and fears (obsessions) that lead to compulsive behaviors. OCD often centers on themes such as a fear of germs or the need to arrange objects in a specific manner. The Obsessive Compulsive Disorder Pipeline Market Report provides the new treatments and drug profiles under therapeutics development.
Obsessive compulsive disorder (OCD) is characterized by unreasonable thoughts and fears (obsessions) that lead to do repetitive behaviors (compulsions). Symptoms include having repeated thoughts or images about many different things, such as fear of germs, dirt, or intruders, acts of violence, hurting loved ones, doing the same rituals over and over such as washing hands, locking and unlocking doors, counting, keeping unneeded items, or repeating the same steps again and again. Risk factor includes family history. Treatment includes antidepressants and psychiatric medications.
Get Discount on this Research Report at http://www.reportsnreports.com/contacts/discount.aspx?name=911446 .
Pharmaceutical and Healthcare latest pipeline guide Obsessive Compulsive Disorder Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Obsessive Compulsive Disorder (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
Key Company Profiles are AbbVie Inc, Addex Therapeutics Ltd, Amorsa Therapeutics Inc, C4X Discovery Holdings PLC, Omeros Corp and Savant HWP Inc.
Obsessive Compulsive Disorder Drug Profiles
18 MC Drug Profile, ADX 71743 Drug Profile, ADX 88178 Drug Profile, fluvoxamine maleate Drug Profile, HUF 101 Drug Profile, OMS 527 Drug Profile, Small Molecules for Autism Spectrum Disorders and Obsessive Compulsive Disorders – Drug, Small Molecules to Antagonize Orexin 1 Receptor for CNS Disorders Drug Profile, Small Molecules to Target NMDA Receptor for Obsessive Compulsive Disorder Drug Profile.
Inquire more on this Research Report at http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=911446
Obsessive Compulsive Disorder (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Scope
The pipeline guide provides a snapshot of the global therapeutic landscape of Obsessive Compulsive Disorder (Central Nervous System).
The pipeline guide reviews pipeline therapeutics for Obsessive Compulsive Disorder (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry specific sources.
The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
The pipeline guide reviews key companies involved in Obsessive Compulsive Disorder (Central Nervous System) therapeutics and enlists all their major and minor projects.
The pipeline guide evaluates Obsessive Compulsive Disorder (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
The pipeline guide reviews latest news related to pipeline therapeutics for Obsessive Compulsive Disorder (Central Nervous System)
Purchase this research report Direct from http://www.reportsnreports.com/purchase.aspx?name=911446 .
Table of Contents:
Obsessive Compulsive Disorder Overview
Obsessive Compulsive Disorder Therapeutics Development
Obsessive Compulsive Disorder Pipeline Overview
Obsessive Compulsive Disorder Pipeline by Companies
Obsessive Compulsive Disorder Pipeline by Universities/Institutes
Products under Development by Companies
Obsessive Compulsive Disorder Therapeutics Assessment
Obsessive Compulsive Disorder Companies Involved in Therapeutics Development
Obsessive Compulsive Disorder Drug Profiles
Obsessive Compulsive Disorder Dormant Projects
Obsessive Compulsive Disorder Product Development Milestones

List of Tables.
Number of Products under Development for Obsessive-Compulsive Disorder, H1 2017
Number of Products under Development by Companies, H1 2017
Products under Development by Companies, H1 2017
Number of Products by Stage and Target, H1 2017
Number of Products by Stage and Mechanism of Action, H1 2017
Number of Products by Stage and Route of Administration, H1 2017
Number of Products by Stage and Molecule Type, H1 2017
Obsessive-Compulsive Disorder - Pipeline by AbbVie Inc, H1 2017
Obsessive-Compulsive Disorder - Pipeline by Addex Therapeutics Ltd, H1 2017
Obsessive-Compulsive Disorder - Pipeline by Amorsa Therapeutics Inc, H1 2017
Obsessive-Compulsive Disorder - Pipeline by C4X Discovery Holdings PLC, H1 2017
Obsessive-Compulsive Disorder - Pipeline by Omeros Corp, H1 2017
Obsessive-Compulsive Disorder - Pipeline by Savant HWP Inc, H1 2017
Obsessive-Compulsive Disorder - Dormant Projects, H1 2017
Obsessive-Compulsive Disorder - Discontinued Products, H1 2017

About Us:
ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in depth market research studies of over 5000 micro markets. Order report by calling ReportsnReports.com at +1 888 391 5441 OR send an email on [email protected] with your contact details.